-
1
-
-
33644647027
-
In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgendependent prostate cancer cell line
-
H.C. Chang, S.C. Chen, J. Chen and J.T. Hsieh, In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgendependent prostate cancer cell line, J Formos Med Assoc 104 (2005), 652-658.
-
(2005)
J Formos Med Assoc
, vol.104
, pp. 652-658
-
-
Chang, H.C.1
Chen, S.C.2
Chen, J.3
Hsieh, J.T.4
-
2
-
-
67349225032
-
Coactivator selective regulation of androgen receptor activity
-
I.U. Agoulnik and N.L. Weigel, Coactivator selective regulation of androgen receptor activity, Steroids 74 (2009), 669-674.
-
(2009)
Steroids
, vol.74
, pp. 669-674
-
-
Agoulnik, I.U.1
Weigel, N.L.2
-
3
-
-
8344272750
-
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor
-
Z.Kang, O.A. Jänne and J.J. Palvimo, Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor, Mol Endocrinol 18 (2004), 2633-2648.
-
(2004)
Mol Endocrinol
, vol.18
, pp. 2633-2648
-
-
Kang, Z.1
Jänne, O.A.2
Palvimo, J.J.3
-
4
-
-
34547864236
-
Histone deacetylase inhibitors: Molecular mechanisms of action
-
W.S.Xu,R.B. Parmigiani and P.A.Marks, Histone deacetylase inhibitors: Molecular mechanisms of action, Oncogene 26 (2007), 5541-5552.
-
(2007)
Oncogene
, vol.26
, pp. 5541-5552
-
-
Xu, W.S.1
Parmigiani, R.B.2
Marks, P.A.3
-
5
-
-
43049119236
-
The use of diversity profiling to characterize chemical modulators of the histone deacetylases
-
L. Blackwell, J. Norris, C.M. Suto and W.P. Janzen, The use of diversity profiling to characterize chemical modulators of the histone deacetylases, Life Sci 82 (2008), 1050-1058.
-
(2008)
Life Sci
, vol.82
, pp. 1050-1058
-
-
Blackwell, L.1
Norris, J.2
Suto, C.M.3
Janzen, W.P.4
-
6
-
-
0034663815
-
Both corepressor proteins SMRT and NCoR exist in large protein complexes containing HDAC3
-
J. Li, J. Wang, J. Wang, Z. Nawaz, M.L. Johnson, J. Qin and J.Wong, Both corepressor proteins SMRT and NCoR exist in large protein complexes containing HDAC3, EMBO J 19(16) (2000), 4342-4350.
-
(2000)
EMBO J
, vol.19
, Issue.16
, pp. 4342-4350
-
-
Li, J.1
Wang, J.2
Wang, J.3
Nawaz, Z.4
Johnson, M.L.5
Qin, J.6
Wong, J.7
-
7
-
-
0036211850
-
The NCoRHDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2
-
J. Zhang, M. Kalkum, B.T. Chait and R.G. Roeder, The NCoRHDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2, Mol Cell 9 (2002), 611-623.
-
(2002)
Mol Cell
, vol.9
, pp. 611-623
-
-
Zhang, J.1
Kalkum, M.2
Chait, B.T.3
Roeder, R.G.4
-
8
-
-
0344405718
-
Purification and functional characterization of the human NCoR complex: The roles of HDAC3 TBL1 and TBLR1
-
H. Yoon, D.W. Chan, Z. Huang, J. Li, J.D. Fondell, J. Qin and J. Wong, Purification and functional characterization of the human NCoR complex: the roles of HDAC3 TBL1 and TBLR1, EMBO J 22 (2003), 1336-1346.
-
(2003)
EMBO J
, vol.22
, pp. 1336-1346
-
-
Yoon, H.1
Chan, D.W.2
Huang, Z.3
Li, J.4
Fondell, J.D.5
Qin, J.6
Wong, J.7
-
9
-
-
30344477367
-
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
-
S.Minucci and P.G. Pelicci, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nat Rev Cancer 6 (2006), 38-51.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 38-51
-
-
Minucci, S.1
Pelicci, P.G.2
-
10
-
-
0036218774
-
The amino terminus of the human AR is target for corepressor action and antihormone agonism
-
H. Dotzlaw, U. Moehren, S. Mink, A.C.B. Cato, J.A. Iñigues Lluhí and A. Baniahmad, The amino terminus of the human AR is target for corepressor action and antihormone agonism, Mol Endocrinol 16 (2002), 661-673.
-
(2002)
Mol Endocrinol
, vol.16
, pp. 661-673
-
-
Dotzlaw, H.1
Moehren, U.2
Mink, S.3
Cato, A.C.B.4
Inigues Lluhí, J.A.5
Baniahmad, A.6
-
11
-
-
0034664769
-
Combinatorial roles of the nuclear receptor corepressor in transcription and development
-
K. Jepsen, O. Hermanson, T.M. Onami, A.S. Gleiberman, V. Lunyak, R.J.McEvilly, R. Kurokawa, V. Kumar, F. Liu, E. Seto, S.M. Hedrick, G. Mandel, C. Glass, D.W. Rose and M.G. Rosenfeld, Combinatorial roles of the nuclear receptor corepressor in transcription and development, Cell 102 (2000), 753-763.
-
(2000)
Cell
, vol.102
, pp. 753-763
-
-
Jepsen, K.1
Hermanson, O.2
Onami, T.M.3
Gleiberman, A.S.4
Lunyak, V.5
McEvilly, R.J.6
Kurokawa, R.7
Kumar, V.8
Liu, F.9
Seto, E.10
Hedrick, S.M.11
Mandel, G.12
Glass, C.13
Rose, D.W.14
Rosenfeld, M.G.15
-
12
-
-
67650090545
-
Histone deacetylase inhibitors: Potential in cancer therapy
-
PA. Marks and W.S. Xu, Histone deacetylase inhibitors: Potential in cancer therapy, J Cell Biochem 107 (2009), 600-608.
-
(2009)
J Cell Biochem
, vol.107
, pp. 600-608
-
-
Marks, P.A.1
Xu, W.S.2
-
13
-
-
0041347519
-
Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?
-
R.W. Johnstone, J.D. Licht, Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target? Cancer Cell 4 (2002), 13-18.
-
(2002)
Cancer Cell
, vol.4
, pp. 13-18
-
-
Johnstone, R.W.1
Licht, J.D.2
-
14
-
-
4644262388
-
Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation - rescue of transcriptionally compromised mutants
-
C.G. Korkmaz, K. Frønsdal, Y. Zhang, P.I. Lorenzo and F. Saatcioglu, Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation - rescue of transcriptionally compromised mutants, J Endocrinol 182 (2004), 377-389.
-
(2004)
J Endocrinol
, vol.182
, pp. 377-389
-
-
Korkmaz, C.G.1
Frønsdal, K.2
Zhang, Y.3
Lorenzo, P.I.4
Saatcioglu, F.5
-
15
-
-
33645125545
-
Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptorpositive prostate cancer cells
-
O.W. Roklin, R.B. Glover, N.V. Guseva, A.F. Taghiyev, K.G. Kohlgraf and M.B. Cohen, Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptorpositive prostate cancer cells, Mol Cancer Res 4 (2006), 113-123.
-
(2006)
Mol Cancer Res
, vol.4
, pp. 113-123
-
-
Roklin, O.W.1
Glover, R.B.2
Guseva, N.V.3
Taghiyev, A.F.4
Kohlgraf, K.G.5
Cohen, M.B.6
-
16
-
-
12344272623
-
Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells
-
K. Frønsdal and F. Saatcioglu, Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells, Prostate 62 (2005), 299-306.
-
(2005)
Prostate
, vol.62
, pp. 299-306
-
-
Frønsdal, K.1
Saatcioglu, F.2
-
17
-
-
35348966849
-
Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer
-
J. Kim, H. Park, J.Y. Im, W.S. Choi and H.S. Kim, Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer, Anticancer Res 27 (2009), 3285-3292.
-
(2009)
Anticancer Res
, vol.27
, pp. 3285-3292
-
-
Kim, J.1
Park, H.2
Im, J.Y.3
Choi, W.S.4
Kim, H.S.5
-
18
-
-
0842277812
-
Histone deacetylase (HDAC) inhibitor activation of p21WAF involves changes in promoteraccociated proteins including HDAC1
-
C.Y. Gui, L. Ngo, W.S. Xu, V.M. Richon and P.A. Marks, Histone deacetylase (HDAC) inhibitor activation of p21WAF involves changes in promoteraccociated proteins including HDAC1, Proc Natl Acad Sci USA 100 (2004), 1241-1246.
-
(2004)
Proc Natl Acad Sci USA
, vol.100
, pp. 1241-1246
-
-
Gui, C.Y.1
Ngo, L.2
Xu, W.S.3
Richon, V.M.4
Marks, P.A.5
-
19
-
-
0025045495
-
Androgen receptor gene expression in human prostate carcinoma cell lines
-
W.D. Tilley, C.M.Wilson,M.Marcelli andM.J.McPhaul, Androgen receptor gene expression in human prostate carcinoma cell lines, Cancer Res 50 (1990), 5382-5386.
-
(1990)
Cancer Res
, vol.50
, pp. 5382-5386
-
-
Tilley, W.D.1
Wilson, C.M.2
Marcelli, M.3
McPhaul, M.J.4
-
20
-
-
39549091486
-
Transcriptional networks inferred from molecular signatures of breast cancer
-
R. Tongbai, G. Idelman, S.H. Nordgard, W. Cui, J.L. Jacobs, C.M. Haggerty, S.J. Chanock, A.L. BørresenDale, G. Livingston, P. Shaunessy, C.H. Chiang, V.N. Kristensen, S. Bilke and K. Gardner, Transcriptional networks inferred from molecular signatures of breast cancer, AmJ Pathol 172 (2008), 495-509.
-
(2008)
Am J Pathol
, vol.172
, pp. 495-509
-
-
Tongbai, R.1
Idelman, G.2
Nordgard, S.H.3
Cui, W.4
Jacobs, J.L.5
Haggerty, C.M.6
Chanock, S.J.7
BørresenDale, A.L.8
Livingston, G.9
Shaunessy, P.10
Chiang, C.H.11
Kristensen, V.N.12
Bilke, S.13
Gardner, K.14
-
21
-
-
0034667457
-
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells
-
M.D. Sadar and M.E. Gleave, Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells, Cancer Res 60 (2000), 5825-5831.
-
(2000)
Cancer Res
, vol.60
, pp. 5825-5831
-
-
Sadar, M.D.1
Gleave, M.E.2
-
22
-
-
18244416617
-
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer
-
H. Kinoshita, Y. Shi, C. Sandefur, L.F. Meisner, C. Chang, A. Chlom, C.R. Reznikoff, G.S. Bova, A. Friedl and D.F. Jarrard, Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer, Cancer Res 60 (2000), 3623-3630.
-
(2000)
Cancer Res
, vol.60
, pp. 3623-3630
-
-
Kinoshita, H.1
Shi, Y.2
Sandefur, C.3
Meisner, L.F.4
Chang, C.5
Chlom, A.6
Reznikoff, C.R.7
Bova, G.S.8
Friedl, A.9
Jarrard, D.F.10
-
23
-
-
0034528599
-
Epigenetic regulation of androgen receptor gene expression in human prostate cancers
-
Nakayama, M. Watanabe, H. Suzuki, M. Toyota, N. Sekita, Y. Hirokawa, A. Mizokami, H. Ito, R. Yatani and T. Shiraishi, Epigenetic regulation of androgen receptor gene expression in human prostate cancers, Lab Invest 80 (2000), 1789-1796.
-
(2000)
Lab Invest
, vol.80
, pp. 1789-1796
-
-
Watanabe, N.M.1
Suzuki, H.2
Toyota, M.3
Sekita, N.4
Hirokawa, Y.5
Mizokami, A.6
Ito, H.7
Yatani, R.8
Shiraishi, T.9
-
24
-
-
27544505676
-
Chromatin modifier enzymes the histone code and cancer
-
H. SantosRosa and C. Caldas, Chromatin modifier enzymes the histone code and cancer, Eur J Cancer 41 (2005), 2381-2402.
-
(2005)
Eur J Cancer
, vol.41
, pp. 2381-2402
-
-
SantosRosa, H.1
Caldas, C.2
-
25
-
-
49349098483
-
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
-
J.S. Carew, F.J. Giles and S.T. Nawrocki, Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy, Cancer Lett 269 (2008), 7-17.
-
(2008)
Cancer Lett
, vol.269
, pp. 7-17
-
-
Carew, J.S.1
Giles, F.J.2
Nawrocki, S.T.3
-
26
-
-
11144333630
-
Reading and function of a histone code involved in targeting corepressor complexes for repression
-
H.Yoon,Y. Choi, P.A. Cole and J.Wong,Reading and function of a histone code involved in targeting corepressor complexes for repression, Mol Cell Biol 25(1) (2005), 324-335.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.1
, pp. 324-335
-
-
Yoon, H.1
Choi, Y.2
Cole, P.A.3
Wong, J.4
-
27
-
-
1842631408
-
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer
-
K. Halkidou, L. Gaughan, S. Cook, H.Y. Leung, D.E. Neal and C.N. Robson, Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer, Prostate 59 (2004), 177-189.
-
(2004)
Prostate
, vol.59
, pp. 177-189
-
-
Halkidou, K.1
Gaughan, L.2
Cook, S.3
Leung, H.Y.4
Neal, D.E.5
Robson, C.N.6
-
28
-
-
38949086502
-
His tone deacetylase 1, 2, and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
-
W. Weichert, A. Röske, V Gekeler, T. Beckers, C. Stephan, K. Jung, F.R. Fritzsche, S. Niespored, C. Denkert, M. Dietel and G. Kristiansen, His tone deacetylase 1, 2, and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy, Br J Cancer 98 (2008), 604-610.
-
(2008)
Br J Cancer
, vol.98
, pp. 604-610
-
-
Weichert, W.1
Röske, A.2
Gekeler, V.3
Beckers, T.4
Stephan, C.5
Jung, K.6
Fritzsche, F.R.7
Niespored, S.8
Denkert, C.9
Dietel, M.10
Kristiansen, G.11
-
29
-
-
59149089556
-
Histone deacetylases are required for androgen receptor function in hormonesensitive and castrate resistant prostate cancer
-
D.S. Welsbie, J. Xu, Y. Chen, L. Borsu, H.I. Scher, N. Rosen and C.L. Sawyers, Histone deacetylases are required for androgen receptor function in hormonesensitive and castrate resistant prostate cancer, Cancer Res 69(3) (2009), 958-966.
-
(2009)
Cancer Res
, vol.69
, Issue.3
, pp. 958-966
-
-
Welsbie, D.S.1
Xu, J.2
Chen, Y.3
Borsu, L.4
Scher, H.I.5
Rosen, N.6
Sawyers, C.L.7
-
30
-
-
0842277812
-
Waf1 involves changes in promoterassociated proteins, including HDACl
-
Waf1 involves changes in promoterassociated proteins, including HDACl, Proc Natl Acad Sci USA 101(5) (2004), 1241-1246.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, Issue.5
, pp. 1241-1246
-
-
Gui, C.Y.1
Ngo, L.2
Xu, W.S.3
Richon, V.M.4
Marks, P.A.5
-
31
-
-
0037383786
-
21Waf1/Cip1 gene
-
21Waf1/Cip1 gene, Mol Cell Biol 23(8) (2003), 2669-2679.
-
(2003)
Mol Cell Biol
, vol.23
, Issue.8
, pp. 2669-2679
-
-
Lagger, G.1
Doetzlhofer, A.2
Schuettengruber, B.3
Haidweger, E.4
Simboeck, E.5
Tischler, J.6
Chiocca, S.7
Suske, G.8
Rotheneder, H.9
Wintersberger, E.10
Seiser, C.11
-
32
-
-
14844353574
-
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors
-
M.J. Peart, G.K. Smyth, R.K. van Laar, D.D. Bowtell, V.M. Richon, P.A.Marks, A.J. Holloway and R.W. Johnstone, Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors, Proc Natl Acad Sci USA 102(10), 3697-3702.
-
Proc Natl Acad Sci USA
, vol.102
, Issue.10
, pp. 3697-3702
-
-
Peart, M.J.1
Smyth, G.K.2
Van Laar, R.K.3
Bowtell, D.D.4
Richon, V.M.5
Marks, P.A.6
Holloway, A.J.7
Johnstone, R.W.8
-
33
-
-
70549105748
-
Phase II, twostage, singlearm trial of the histone deacetylase inhibitor (HDACi) romidepsin inmetastatic castrationresistant prostate cancer (CRPC)
-
L.R. Molife, G. Attard, P.C. Fong, V. Karavasilis, A.H.M. Reid, S. Patterson, C.E. Riggs, Jr., C.Gitano,W.M. Stadler,W. McCulloch, D.Deamaley, C. Parker and J.S. deBono, Phase II, twostage, singlearm trial of the histone deacetylase inhibitor (HDACi) romidepsin inmetastatic castrationresistant prostate cancer (CRPC), Ann Oncol 21 (2010), 109-113.
-
(2010)
Ann Oncol
, vol.21
, pp. 109-113
-
-
Molife, L.R.1
Attard, G.2
Fong, P.C.3
Karavasilis, V.4
Reid, A.H.M.5
Patterson, S.6
Riggs Jr., C.E.7
Gitano, C.8
Stadler, W.M.9
McCulloch, W.10
Deamaley, D.11
Parker, C.12
DeBono, J.S.13
-
34
-
-
33644696512
-
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824
-
L. Chen, S. Meng, H. Wang, P Bali, W. Bai, B. Li, P. Stadia, K.N.Bhalla and J.Wu, Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824, Mol Cancer Ther 4(9) (2005), 1311-1319.
-
(2005)
Mol Cancer Ther
, vol.4
, Issue.9
, pp. 1311-1319
-
-
Chen, L.1
Meng, S.2
Wang, H.3
Bali, P.4
Bai, W.5
Li, B.6
Stadia, P.7
Bhalla, K.N.8
Wu, J.9
-
35
-
-
33744792310
-
Senzors and signals: A coactivator/corepressor/epigenetic code for integrating signaldependent programs of transcriptional response
-
M.G. Rosenfeld, V.V. Lunyak andC.K.Glass, Senzors and signals: a coactivator/corepressor/epigenetic code for integrating signaldependent programs of transcriptional response, Genes Dev 20 (2006), 1405-1428.
-
(2006)
Genes Dev
, vol.20
, pp. 1405-1428
-
-
Rosenfeld, M.G.1
Lunyak, V.V.2
Glass, C.K.3
-
36
-
-
0028944970
-
Regulation of proliferation and production of prostatespecific antigen in androgensensitive prostatic cancer cells LNCaP by dihydrotestosterone
-
C. Lee, D.M. Sutkowski, J.A. Sensibar, D. Kelner, I. Kim, I. Amsel, N. Shaw, G.S. Prins and J.M. Kolzlowski, Regulation of proliferation and production of prostatespecific antigen in androgensensitive prostatic cancer cells LNCaP by dihydrotestosterone, Endocrinology 136 (1995), 796-803.
-
(1995)
Endocrinology
, vol.136
, pp. 796-803
-
-
Lee, C.1
Sutkowski, D.M.2
Sensibar, J.A.3
Kelner, D.4
Kim, I.5
Amsel, I.6
Shaw, N.7
Prins, G.S.8
Kolzlowski, J.M.9
-
37
-
-
0038475953
-
Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT
-
G. Liao, L.Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J.C. Ghosh, H. Li and J.D. Chen, Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT, J Biol Chem 278(7), 5052-5061.
-
J Biol Chem
, vol.278
, Issue.7
, pp. 5052-5061
-
-
Liao, G.1
Chen, L.Y.2
Zhang, A.3
Godavarthy, A.4
Xia, F.5
Ghosh, J.C.6
Li, H.7
Chen, J.D.8
-
38
-
-
33746507785
-
The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonistand antagonistregulated transcription by androgen receptor
-
H. Yoon and J. Wong, The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonistand antagonistregulated transcription by androgen receptor, Mol Endocrinol 20 (2006), 1048-1060.
-
(2006)
Mol Endocrinol
, vol.20
, pp. 1048-1060
-
-
Yoon, H.1
Wong, J.2
-
39
-
-
0037925529
-
A SANT motif in the SMRT corepressor interprets the histone code and promoter histone deacetylation
-
J. Yu, Y. Li, T. Ishizuka, M.G. Guenther and M.A. Lazar, A SANT motif in the SMRT corepressor interprets the histone code and promoter histone deacetylation, EMBO J 22(13) (2003), 3403-3410.
-
(2003)
EMBO J
, vol.22
, Issue.13
, pp. 3403-3410
-
-
Yu, J.1
Li, Y.2
Ishizuka, T.3
Guenther, M.G.4
Lazar, M.A.5
|